186 related articles for article (PubMed ID: 34585664)
1. 3'HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression.
Himadewi P; Wang XQD; Feng F; Gore H; Liu Y; Yu L; Kurita R; Nakamura Y; Pfeifer GP; Liu J; Zhang X
Elife; 2021 Sep; 10():. PubMed ID: 34585664
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin.
Changsri K; Akkarapathumwong V; Jamsai D; Winichagoon P; Fucharoen S
Int J Hematol; 2006 Apr; 83(3):229-37. PubMed ID: 16720553
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
Elife; 2022 Feb; 11():. PubMed ID: 35147495
[TBL] [Abstract][Full Text] [Related]
4. Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH.
Braghini CA; Costa FC; Fedosyuk H; Neades RY; Novikova LV; Parker MP; Winefield RD; Peterson KR
Exp Biol Med (Maywood); 2016 Apr; 241(7):697-705. PubMed ID: 26946532
[TBL] [Abstract][Full Text] [Related]
5. A natural regulatory mutation in the proximal promoter elevates fetal
Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
[TBL] [Abstract][Full Text] [Related]
6. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
Kang J; Kim YW; Park S; Kang Y; Kim A
FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
[TBL] [Abstract][Full Text] [Related]
7. Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.
Topfer SK; Feng R; Huang P; Ly LC; Martyn GE; Blobel GA; Weiss MJ; Quinlan KGR; Crossley M
Blood; 2022 Apr; 139(14):2107-2118. PubMed ID: 35090172
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.
Venkatesan V; Srinivasan S; Babu P; Thangavel S
Mol Cell Biol; 2020 Dec; 41(1):. PubMed ID: 33077498
[TBL] [Abstract][Full Text] [Related]
9. Increased gamma-globin gene expression in beta-thalassemia intermedia patients correlates with a mutation in 3'HS1.
Papachatzopoulou A; Kaimakis P; Pourfarzad F; Menounos PG; Evangelakou P; Kollia P; Grosveld FG; Patrinos GP
Am J Hematol; 2007 Nov; 82(11):1005-9. PubMed ID: 17654503
[TBL] [Abstract][Full Text] [Related]
10. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
[TBL] [Abstract][Full Text] [Related]
11. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.
Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A
Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807
[TBL] [Abstract][Full Text] [Related]
12. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
13. Engineering of the endogenous
Boontanrart MY; Mächler E; Ponta S; Nelis JC; Preiano VG; Corn JE
Elife; 2023 Jun; 12():. PubMed ID: 37265399
[TBL] [Abstract][Full Text] [Related]
14. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies.
Li C; Georgakopoulou A; Newby GA; Everette KA; Nizamis E; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36006707
[TBL] [Abstract][Full Text] [Related]
15. The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster.
Feingold EA; Forget BG
Blood; 1989 Nov; 74(6):2178-86. PubMed ID: 2478223
[TBL] [Abstract][Full Text] [Related]
16. The human β-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites.
Kim J; Kang J; Kim YW; Kim A
FASEB J; 2021 Jun; 35(6):e21669. PubMed ID: 34033138
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of hereditary persistence of fetal hemoglobin.
Forget BG
Ann N Y Acad Sci; 1998 Jun; 850():38-44. PubMed ID: 9668525
[TBL] [Abstract][Full Text] [Related]
18. A functional element necessary for fetal hemoglobin silencing.
Sankaran VG; Xu J; Byron R; Greisman HA; Fisher C; Weatherall DJ; Sabath DE; Groudine M; Orkin SH; Premawardhena A; Bender MA
N Engl J Med; 2011 Sep; 365(9):807-14. PubMed ID: 21879898
[TBL] [Abstract][Full Text] [Related]
19. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Wienert B; Martyn GE; Funnell APW; Quinlan KGR; Crossley M
Trends Genet; 2018 Dec; 34(12):927-940. PubMed ID: 30287096
[TBL] [Abstract][Full Text] [Related]
20. Triplex-forming peptide nucleic acids induce heritable elevations in gamma-globin expression in hematopoietic progenitor cells.
Chin JY; Reza F; Glazer PM
Mol Ther; 2013 Mar; 21(3):580-7. PubMed ID: 23337982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
